By Rob Curran
Incyte tightened the revenue forecast for its Jakafi product line in 2023.
The biotech company now anticipates net product revenue between $2.59 billion and $2.62 billion from Jakafi for the whole year, compared with a prior range between $2.59 billion and $2.63 billion.
Incyte…
Read the full article here